9783846584859 - A Virtual Screening & Molecular Docking Study of Thiadiazoles:: Inhibitory activity of Thiadiazoles on Protein Kinase PKnB from Mycobacterium Tuberculosis de Raj, U... (6 resultados)

Taschenbuch. Condición: Neu. A Virtual Screening & Molecular Docking Study of Thiadiazoles: | Inhibitory activity of Thiadiazoles on Protein Kinase PKnB from Mycobacterium Tuberculosis | Utkarsh Raj (u. a.) | Taschenbuch | 56 S. | Englisch | 2012 | LAP LAMBERT Academic Publishing | EAN 9783846584859 | Verantwortliche Person für die EU: BoD - Books on Demand, In de Tarpen 42, 22848 Norderstedt, info[at]bod[dot]de | Anbieter: preigu.

Paperback. Condición: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Taschenbuch. Condición: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In structure-based drug design, the three-dimensional structure of a drug target interacting with small molecules is used to guide drug discovery. 'Structure-based drug design represents the idea that you can see exactly how your molecule interacts with its target protein. This structural information can be obtained with X-ray crystallography or nuclear magnetic resonance spectroscopy (NMR). Originally, structure-based drug design was equated with de novo design or building a molecule from the ground up. Structure-based drug design relies on knowledge of the three dimensional structure of the biological target obtained through methods such as x-ray crystallography or NMR spectroscopy. If an experimental structure of a target is not available, it may be possible to create a homology model of the target based on the experimental structure of a related protein. As experimental methods such as X-ray crystallography and NMR develop, the amount of information concerning 3D structures of biomolecular targets has increased dramatically. Current methods for structure-based drug design can be divided roughly into two categories : Ligand-based drug design & receptor-based drug design. 56 pp. Englisch.

Condición: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Raj UtkarshI am pursuing M.Tech Biotech from GBU,India.My area of interests are CAAD,Microarray Analysis etc.I had done various projects which got accepted at National / International level & got two publications in Journal of Comput.

Taschenbuch. Condición: Neu. This item is printed on demand - Print on Demand Titel. Neuware -In structure-based drug design, the three-dimensional structure of a drug target interacting with small molecules is used to guide drug discovery. 'Structure-based drug design represents the idea that you can see exactly how your molecule interacts with its target protein.'This structural information can be obtained with X-ray crystallography or nuclear magnetic resonance spectroscopy (NMR). Originally, structure-based drug design was equated with de novo design or building a molecule from the ground up. Structure-based drug design relies on knowledge of thethree dimensional structureof the biological target obtained through methods such asx-ray crystallographyorNMR spectroscopy. If an experimental structure of a target is not available, it may be possible to create ahomology modelof the target based on the experimental structure of a related protein. As experimental methods such as X-ray crystallography and NMR develop, the amount of information concerning 3D structures of biomolecular targets has increased dramatically. Current methods for structure-based drug design can be divided roughly into two categories : Ligand-based drug design & receptor-based drug design.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 56 pp. Englisch.

Taschenbuch. Condición: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In structure-based drug design, the three-dimensional structure of a drug target interacting with small molecules is used to guide drug discovery. 'Structure-based drug design represents the idea that you can see exactly how your molecule interacts with its target protein. This structural information can be obtained with X-ray crystallography or nuclear magnetic resonance spectroscopy (NMR). Originally, structure-based drug design was equated with de novo design or building a molecule from the ground up. Structure-based drug design relies on knowledge of the three dimensional structure of the biological target obtained through methods such as x-ray crystallography or NMR spectroscopy. If an experimental structure of a target is not available, it may be possible to create a homology model of the target based on the experimental structure of a related protein. As experimental methods such as X-ray crystallography and NMR develop, the amount of information concerning 3D structures of biomolecular targets has increased dramatically. Current methods for structure-based drug design can be divided roughly into two categories : Ligand-based drug design & receptor-based drug design.